Geneva Advisors’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $1.05M | Sell |
10,355
-225
| -2% | -$22.8K | 0.02% | 355 |
|
|
2017
Q1 | $1.22M | Sell |
10,580
-150
| -1% | -$17.3K | 0.02% | 310 |
|
|
2016
Q4 | $1.29M | Buy |
10,730
+2,482
| +30% | +$298K | 0.03% | 278 |
|
|
2016
Q3 | $926K | Sell |
8,248
-725
| -8% | -$81.4K | 0.02% | 338 |
|
|
2016
Q2 | $1.11M | Buy |
8,973
+1,053
| +13% | +$130K | 0.02% | 292 |
|
|
2016
Q1 | $890K | Buy |
7,920
+1,030
| +15% | +$116K | 0.02% | 322 |
|
|
2015
Q4 | $749K | Buy |
6,890
+900
| +15% | +$97.8K | 0.01% | 345 |
|
|
2015
Q3 | $598K | Buy |
5,990
+2,950
| +97% | +$295K | 0.01% | 361 |
|
|
2015
Q2 | $347K | Sell |
3,040
-120
| -4% | -$13.7K | 0.01% | 497 |
|
|
2015
Q1 | $330K | Sell |
3,160
-4,692
| -60% | -$490K | 0.01% | 498 |
|
|
2014
Q4 | $945K | Sell |
7,852
-57,600
| -88% | -$6.93M | 0.02% | 309 |
|
|
2014
Q3 | $9.58M | Sell |
65,452
-22,122
| -25% | -$3.24M | 0.18% | 96 |
|
|
2014
Q2 | $14.6M | Sell |
87,574
-25,589
| -23% | -$4.27M | 0.27% | 91 |
|
|
2014
Q1 | $22.5M | Buy |
113,163
+36,231
| +47% | +$7.19M | 0.41% | 75 |
|
|
2013
Q4 | $14.7M | Buy |
76,932
+18,542
| +32% | +$3.54M | 0.27% | 84 |
|
|
2013
Q3 | $9.88M | Buy |
58,390
+19,409
| +50% | +$3.28M | 0.21% | 91 |
|
|
2013
Q2 | $5.91M | Buy |
+38,981
| New | +$5.91M | 0.14% | 103 |
|